Atlas Trials

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

Clinical trial NCT05952934 · RECRUITING

Trial details

NCT number
NCT05952934
Sponsor
University of Arkansas
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Squamous Cell Carcinoma of Head and Neck
Start date
2024-02-12
Primary completion
2031-07-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.